Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

We have observed 5 EP applications Michael John Lubienski has served for within the last five+ years. (We consider all applications which have an EP A1 publication dated after December 14, 2012). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP12771540

FUSION PROTEINS AND COMBINATION VACCINES COMPRISING HAEMOPHILUS INFLUENZAE PROTEIN E AND PILIN A

IPC classification:
A61K 39/145, A61K 39/385, A61P 31/16, A61P 37/04, C07K 14/285, C07K 19/00, C12N 15/00, C12P 21/02
Applicant:
GlaxoSmithKline Biologicals SA
Agent:
Multiple attorneys, GlaxoSmithKline
Status:
GRANT OF PATENT INTENDED
EP11707193

IMMUNOGENIC COMPOSITION

IPC classification:
A61K 39/095, A61K 39/116, C07K 14/22
Applicant:
GlaxoSmithKline Biologicals SA
Agent:
Multiple attorneys, GlaxoSmithKline
Status:
EXAMINATION REQUESTED
EP11707192

IMMUNOGENIC COMPOSITION

IPC classification:
A61K 39/095, A61K 39/116, C07K 14/22
Applicant:
GlaxoSmithKline Biologicals SA
Agent:
Multiple attorneys, GlaxoSmithKline
Agent:
Michael John Lubienski, GlaxoSmithKline Intellectual Property Management Limited
Status:
EXAMINATION REQUESTED
EP11757268

VACCINE AGAINST N. MENINGITIDIS

IPC classification:
A61K 39/095
Applicant:
GlaxoSmithKline Biologicals SA
Agent:
Multiple attorneys, GlaxoSmithKline
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP11708449

VACCINE COMPOSITION

IPC classification:
A61K 39/095, A61K 39/116, C07K 14/22
Applicant:
GlaxoSmithKline Biologicals SA
Agent:
Multiple attorneys, GlaxoSmithKline
Agent:
Michael John Lubienski, GlaxoSmithKline Intellectual Property Management Limited
Status:
APPLICATION DEEMED TO BE WITHDRAWN

Please Sign in to use this feature